Project Code: 10445941
Faculty: Liggins Institute
Department: Liggins Institute
Main Supervisor: Dist Prof Jane Harding
Application open date: 19 Feb 2019
Enrolment information: NZ Citizens, NZ Permanent Residents, International
Low blood glucose in newborn babies can cause brain damage. Dextrose gel helps prevent low glucose levels, but its effect on children’s growth and development at school age is unknown.
This project will involve assessing growth, development and behaviour of children at 6-7 years who took part in the hPOD trial of dextrose gel.
Masters or Honours degree or equivalent in a health or education-related discipline and a clinical background. Examples include (but are not limited to) neonatology, nursing, midwifery, paediatrics, obstetrics, developmental psychology, educational psychology, education.
i) To develop a screen-based assessment of cognitive, physical and behavioural skills to be administered at school in 6-7-year old children.
ii) To use this assessment to determine the relationships between early glucose levels, treatment with dextrose gel, and later development in the hPOD cohort.
Here is further information about the hPOD trial.
The supervisors are:
- Distinguished Professor Jane Harding
- Dr Chris McKinlay
- Professor Gavin Brown
- Associate Professor Trecia Wouldes
Harris DL, Weston PJ, Signal M, Chase JG, Harding JE. Dextrose gel for treating neonatal hypoglycaemia: A randomized placebo-controlled trial (The Sugar Babies Study). Lancet 382: 2077-83, 2013.
Harris DL, Alsweiler JM, Ansell JM, Gamble GD, Thompson B, Wouldes TA, Yu T-Y, Harding JE on behalf of the CHYLD Study Team. Outcome at 2 years after dextrose gel treatment for neonatal hypoglycemia; Follow up of a randomized trial. Journal of Pediatrics 170: 545-59, 2016. http://dx.doi.org/10.1016/j.jpeds.2015.10.066 .
HegartyJE, Harding JE, GambleGD, CrowtherCA, EdlinR, AlsweilerJM. Prophylactic oral dextrose gel for newborn babies at risk of neonatal hypoglycaemia: A randomised controlled dose-finding trial (the pre-hPOD study). PLOS Medicine 13 (10): e1002155, 2016. doi:10.1371/journal.pmed.1002155.
Hegarty JE, Harding JE, Crowther CA, Brown J, Alsweiler J. Oral dextrose gel to prevent hypoglycaemia in at-risk neonates. Cochrane Database of Systematic Reviews Issue 7. Art. No.: CD012152, 2017. DOI: 10.1002/14651858.CD012152.pub2.
Shah R, Harding JE, Brown J, McKinlay CJD. Neonatal glycemia and neurodevelopmental outcomes: A systematic review and meta-analysis. Neonatology 115:116–126, 2019. DOI:10.1159/000492859
To learn more about the Liggins Institute and what we do visit https://www.auckland.ac.nz/en/liggins.html
- Effect of Early Protein Intake on Later Growth and Development of Children Born Very Preterm
- The current research of Distinguished Professor Jane Elizabeth Harding
- What do families want to know about outcomes after trials of new treatments in pregnancy and the newborn?
- Childhood outcomes after a trial of extra protein for babies born very preterm
- Do lower thresholds for diagnosis of gestational diabetes have later benefits for mothers and babies?